Alcon Inc. (BVMF:A2LC34)

Market Cap	208.97B
Revenue (ttm)	54.28B
Net Income (ttm)	5.58B
Shares Out	n/a
EPS (ttm)	11.19
PE Ratio	37.45
Forward PE	23.78
Dividend	0.12 (0.30%)
Ex-Dividend Date	May 13, 2025

Volume	13
Average Volume	41
Open	39.24
Previous Close	39.76
Day's Range	39.24 - 39.52
52-Week Range	39.20 - 55.60
Beta	n/a
RSI	28.30
Earnings Date	Nov 11, 2025

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ...

• Industry: Ophthalmic Goods
• Founded: 1945
• Employees: 25,599
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: A2LC34

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Financial numbers in USD